Sherie Novotny

Research activity per year

Fingerprint

Dive into the research topics where Sherie Novotny is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

1 Similar Profiles

2 Finished

Developing Treatment, Treatment Validation, and Treatment Scope in the Setting of an Autism Clinical Trial
Novotny, S. (PI)
U.S. Department of Defense
1/1/07 → 12/31/07
Rutgers, The State University
Project: Research
Omega 3 Fatty Acids in the Treatment of Children with Autism Spectrum Disorders
Novotny, S. (PI)
National Center for Complementary and Integrative Health
9/30/06 → 8/31/07
Rutgers, The State University
Project: Research

9 Article
2 Chapter
1 Review article

Divalproex sodium vs placebo for the treatment of irritability in children and adolescents with autism spectrum disorders
Hollander, E., Chaplin, W., Soorya, L., Wasserman, S., Novotny, S., Rusoff, J., Feirsen, N., Pepa, L. & Anagnostou, E., Mar 2010, In: Neuropsychopharmacology. 35, 4, p. 990-998 9 p.
Research output: Contribution to journal › Article › peer-review

Open Access
A double-blind placebo-controlled pilot study of olanzapine in childhood/adolescent pervasive developmental disorder
Hollander, E., Wasserman, S., Swanson, E. N., Chaplin, W., Schapiro, M. L., Zagursky, K. & Novotny, S., Oct 2006, In: Journal of Child and Adolescent Psychopharmacology. 16, 5, p. 541-548 8 p.
Research output: Contribution to journal › Article › peer-review
A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism
Hollander, E., Phillips, A., Chaplin, W., Zagursky, K., Novotny, S., Wasserman, S. & Iyengar, R., Mar 2005, In: Neuropsychopharmacology. 30, 3, p. 582-589 8 p.
Research output: Contribution to journal › Article › peer-review

Open Access
Increased repetitive behaviours and prolactin responsivity to oral m-chlorophenylpiperazine in adults with autism spectrum disorders
Novotny, S., Hollander, E., Phillips, A., Allen, A., Wasserman, S. & Iyengar, R., Sep 2004, In: International Journal of Neuropsychopharmacology. 7, 3, p. 249-254 6 p.
Research output: Contribution to journal › Article › peer-review

Open Access
Outcome Measures for Clinical Drug Trials in Autism
Aman, M. G., Novotny, S., Samango-Sprouse, C., Lecavalier, L., Leonard, E., Gadow, K. D., King, B. H., Pearson, D. A., Gernsbacher, M. A. & Chez, M., Jan 2004, In: CNS Spectrums. 9, 1, p. 36-47 12 p.
Rutgers, The State University
Research output: Contribution to journal › Review article › peer-review

Open Access

Sherie Novotny

Fingerprint

Projects

Developing Treatment, Treatment Validation, and Treatment Scope in the Setting of an Autism Clinical Trial

Omega 3 Fatty Acids in the Treatment of Children with Autism Spectrum Disorders

Research output

Divalproex sodium vs placebo for the treatment of irritability in children and adolescents with autism spectrum disorders

A double-blind placebo-controlled pilot study of olanzapine in childhood/adolescent pervasive developmental disorder

A placebo controlled crossover trial of liquid fluoxetine on repetitive behaviors in childhood and adolescent autism

Increased repetitive behaviours and prolactin responsivity to oral m-chlorophenylpiperazine in adults with autism spectrum disorders

Outcome Measures for Clinical Drug Trials in Autism